we remain committed to translating rigorous, peer-reviewed cellular science into real therapeutic applications.
Latest posts 5
It's one of several patents built on the foundational research program we developed, and its issuance is a meaningful milestone in carrying that work forward.
We're grateful to the researchers, who supported this work.
We're grateful to the researchers, who supported this work.
Dr. Sheetz spent his career as a pioneer in cellular mechanotransduction — the study of how physical force shapes cell behavior. This patent reflects that legacy: a device-based approach using ultrasound immersion to deliver targeted mechanical therapy.
I am proud to announce a granted U.S. patent to Mechanobiologics. We have been awarded U.S. Patent No. 12,714,885, "Systems and Methods for Immersion Mechanotherapy" — protecting technology developed by our founder, Dr. Michael P. Sheetz, and our team.
